PSI Pharmaceutical Society of Ireland PSI Pharmaceutical Society of Ireland
PSI Pharmaceutical Society of Ireland   home > Publications > Practice Notices
   
PSI Pharmaceutical Society of Ireland
divider News divider Pharmacy Act 2007 divider Council divider Registration divider Education divider Standards divider Publications  

divider line
arrow Publications
divider line
divider line
arrow Irish Pharmacy Journal - Pharmaceutical Society
divider line
divider line
arrow Legislation
divider line
divider line
arrow Press Releases 2010
divider line
divider line
arrow Press Releases 2009
divider line
divider line
arrow Press Releases 2008
divider line
divider line
arrow Annual Reports
divider line
divider line
arrow Practice Notices
divider line
divider line
arrow Ethics Articles
divider line
divider line
arrow Submissions
divider line
divider line
arrow Book Club
divider line

2009 Practice Notices

Practice Notice 6
2009
11 June: High Tech
The PSI has issued the following notice in relation to the dispensing and supply of those medicinal products covered by the High Tech Scheme. This notice has also been sent by email to the superintendent and supervising pharmacists of registered retail pharmacy businesses for their attention. Click here to view notice.

Practice Notice 5 2009
5 June: Advertising and Promotion of Medicinal Products on the basis of price or quantity discounts
The PSI has issued the following notice in relation to advertising and promotion of medicinal products. This notice has also been sent by email to the superintendent and supervising pharmacists of registered retail pharmacy businesses for their attention. Click here to view notice.


Practice Notice 4 2009
27 April: Supply of Orlistat (Alli®)
The PSI has issued the following notice regarding the control of the supply of Orlistat (Alli®). This notice has also been sent by email to the superintendent and supervising pharmacists of registered retail pharmacy businesses for their attention. Click here to view notice.


Practice Notice 3
2009
31 March: Good Dispensing Practice – Control of the Supply of “prescription only” Medicinal Products The PSI has issued the following notice regarding the control of the supply of "prescription only" medicinal products. This notice has also been sent by email to the superintendent and supervising pharmacists of registered retail pharmacy businesses for their attention. Click here to view notice.


Practice Notice 2 2009
27 February: Letter to Supervising Pharmacists Concerning Paracetamol-containing Products
The PSI has issued the following notice regarding the supply of medicinal products containing paracetamol. This notice has also been sent by email to the superintendent and supervising pharmacists of registered retail pharmacy businesses for their attention. Click here to view notice.


Practice Notice 1 2009
1 January: Regulation of Retail Pharmacy Businesses Regulations 2008

The PSI has issued a practice notice in relation to the Regulation of Retail Pharmacy Businesses Regulations 2008. Click here to read the notice in full.


2008 and Earlier


Practice Notice - Good Dispensing Policy: Methotrexate

The Pharmacy Act 2007 emphasises the important role of both the supervising and superintendent pharmacists, and provides for an appropriate mechanism of management and accountability in the supply of health and pharmaceutical care, and medicinal products to patients. This notice suggests specific points in relation to the safe management of the dispensing of oral methotrexate. Click to view the notice in full.



Dispensing of Prescription Only Medicines - Faxes

Dispensing involves the complete process which occurs from receipt of the prescription or request at the pharmacy, to the prescribed item or medicine being collected by the patient or patient’s representative.  When dispensing the patient is the primary focus, and the prescribed medicines must be assessed as being appropriate for that individual. Any dispensed medicines must be delivered to him/her in a manner which reflects diligence and care in the receipt, review, assembling, checking, recording and dispatch. The use of faxes to facilitate the process of dispensing is practical, in certain instances, however the use of a fax to provide the legal entitlement to dispense is not appropriate. Click to view notice in full.

Practice Notice - Prescriptions for CD2 drugs

The Pharmaceutical Society of Ireland wishes to remind pharmacists of the necessity to be cognisant of and adhere to the provisions of the Misuse of Drugs Regulations 1988-2007, and in particular of the controls in place on products having significant abuse and misuse potential, i.e. substances listed in Schedule 2 of the Misuse of Drugs Regulations, of all formulation types.

When presented with a prescription for such a product, the pharmacist must ensure that the practitioner issuing the prescription/requisition is entitled and authorised to do so. If a situation occurs where a prescription/requisition is presented in an area outside of what would be expected to be the normal catchment area of that medical practice or practitioner, it is advised that the Medical Council register of medical practitioners be consulted to ensure that the practitioner is currently registered, and has not been removed from the register either on a voluntary or involuntary basis. The Medical Council register is available online at www.medicalcouncil.ie. The pharmacist must be satisfied that the practitioner is registered.
 
Schedule 2 controlled drugs should only be supplied on foot of a valid prescription or requisition and the pharmacist should satisfy themselves that the prescription or requisition is valid and appropriate. Pharmacists are reminded in particular of the provisions under Article 14 (f), relating to the supply of controlled drugs, where supply should not be made “unless he is satisfied as to the identity of the person for whose treatment the prescription is issued and, in the case of the supply being made to a representative of the said person, unless he is satisfied that the said representative is a bona fide representative of the said person”.

For prescriptions, the practitioner issuing the prescription must be entitled and authorised to do so. The pharmacist must ensure that the person presenting it is either the patient named in the prescription or his representative; the pharmacist must satisfy himself that he can correctly interpret the prescription and can safely and properly dispense what is prescribed, and having exercised due diligence and care, satisfy himself that it is safe and in the best interests of the patient concerned to dispense the prescription.

For requisitions, the practitioner requesting the supply must be entitled and authorised to do so and the pharmacist must be satisfied as to the reason specified by the practitioner which necessitates and authorises the supply.



Practice Notice - Repeat Dispensing of CD2 and CD3

It has come to the attention of the Pharmaceutical Society of Ireland, the pharmacy regulator, that the provisions of the Misuse of Drugs Regulations 1988, in respect of the repeating of Schedule 2 and 3 controlled drugs, may currently be subject to certain misinterpretations in practice. The following clarification is issued to remove any ambiguity which may exist in this respect.

The repeat dispensing of a Schedule 2 or Schedule 3 controlled drug is not facilitated by these regulations, irrespective of any written direction on a prescription to do so. Specific prescription writing requirements apply which necessitate that either the total quantity of the drug or preparation or the number of dosage units to be supplied must be indicated in the prescriber’s own handwriting in both figures and words. A pharmacist dispensing a prescription for a CD2 or CD3 drug must ensure that it conforms to this requirement and that the prescription is retained at the pharmacy practice from where it was dispensed. Once a pharmacist dispenses any quantity of a CD2 or CD3 preparation the prescription authorising such supply must be retained.
 
Provision is made for the supply of a medicinal preparation in instalments – this facilitates the controlled supply of a potent medicinal product if the practitioner deems this to be appropriate. In the case of a prescription for a total quantity intended to be dispensed by instalments, instructions must be specified which detail the total quantity of product, the quantity to be dispensed at each instalment, the number of instalments and the intervals between instalments to be observed when dispensing. In this instance the prescription must be retained at the original pharmacy where the first instalment is supplied and the patient must return to this pharmacy practice.  

Any further queries in respect of this matter may be addressed by post to the offices of the Society at 18 Shrewsbury Road, Ballsbridge, Dublin 4 or by e-mail to info@pharmaceuticalsociety.ie

   

Search our Registers

Click here to search our public registers



Registrant Login

Click here to access the PSI online facility

 

   
 

 

[LINK WILL OPEN NEW WINDOW] Level A conformance icon, W3C-WAI Web Content Accessibility Guidelines 1.0 [LINK WILL OPEN NEW WINDOW] Valid XHTML 1.0! [LINK WILL OPEN NEW WINDOW] Valid CSS !